Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University Hospitals-Reference-Cited by-同舟云学术

Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University Hospitals

Published:2016-10 Issue: Volume:66 Page:75-82
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Tlemsani Camille,Mir Olivier,Psimaras Dimitri,Vano Yann-Alexandre,Ducreux Michel,Escudier Bernard,Rousseau Benoit,Loirat Delphine,Ceccaldi Bernard,André Thierry,Goldwasser François,Ricard Damien

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Anti-VEGF therapies in the clinic;Meadows;Cold Spring Harb Perspect Med,2012

2. Targeting the VEGF signaling pathway in cancer therapy;Waldner;Expert Opin Ther Targets,2012

3. Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis;Zuo;PLoS One,2014

4. Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis;Qi;Br J Clin Pharmacol,2013

5. Management of hypertension in angiogenesis inhibitor-treated patients;Izzedine;Ann Oncol,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuro-ophthalmic complications of modern anti-cancer drugs;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-02-12

2. Neurological complications of immunotherapy and monoclonal antibody therapy;Neurological Complications of Systemic Cancer and Antineoplastic Therapy;2022

3. Clinical Effect of Transoral Laser Surgery in the Treatment of Early Glottic Carcinoma;Indian Journal of Pharmaceutical Sciences;2021

4. Leucoencéphalopathie postérieure réversible post-chimiothérapie par carboplatine et paclitaxel;Bulletin du Cancer;2019-12

5. Reversible posterior leukoencephalopathy syndrome induced by apatinib: a case report and literature review;OncoTargets and Therapy;2018-07